An organ transplant is a surgical procedure to replace a healthy organ from a damaged organ. Organ transplant diagnostics are clinical diagnostic tools that help to improve the efficiency of transplantation procedures. HLA typing is of utmost importance in applications such as organ and blood stem cell transplantation. Organs that have been successfully transplanted include the kidneys, heart, liver, lungs, pancreas, and bone marrow transplants. The current study aims to assess the global organ transplant diagnostics market by focusing on products (kits, assays, and consumables) and services catering to end-users, including hospitals and transplants centers, academics and research centers, among others. The current market for organ transplant diagnostics is majorly dominated by manufacturers and service providers such as Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc. (One Lambda), bioMérieux S.A., Illumina, Inc., CareDx, Inc. and Laboratory Corporation of America Holdings.

1. Markets 

2. Industry Insights 

3. Market Dynamics

4. Competitive Landscape

5. Offering, $Million, 2020-2031

6. Transplant, $Million, 2020-2031

7. Application, $Million, 2020-2031

8. Technology, $Million, 2020-2031 

9. End-User, $Million, 2020-2031